Edward W. Holmes serves as Executive at Arcturus Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Edward W. Holmes has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 14, 2024 involved exercising options for 3,131 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 14, 2024 | ARCT | $0 | Option Exercise | 3,131 | $N/A | Discretionary |
Edward W. Holmes currently holds 3,131 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward W. Holmes has been a net neutral trader of ARCT stock. They have purchased $0 and sold $0 worth of shares.
Edward W. Holmes's most recent insider trade was on Jun 14, 2024, when they sold 3,131 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted